Clinical Trial Update: Study of the Pathogenesis and Molecular Mechanism of "YURE" in Internal Intractable Diseases [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studying the pathogenesis and molecular mechanism of YURE in stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• YURE

Snippet

Sponsor: Nanjing University of Traditional Chinese Medicine | Conditions: Stroke | Phase 2 | Status: UNKNOWN